Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Takeda Extends PRA Alliance To Japan With New JV

Executive Summary

Takeda is setting up a new joint venture in Japan to extend its global clinical development partnership with PRA, as part of an ongoing R&D overhaul.

Advertisement

Related Content

Deal Watch: Success Nets CytomX Another $200m From BMS, Up To $3.6bn For Milestones
Deal Watch: Otsuka’s Neurovance Buy Adds ADHD Candidate To CNS Pipeline
Deal Watch: Teva's Sol Barer Leads Buyout Of IO Start-up NexImmune
Refocus, Optimize, Externalize: Takeda Overhauls Global R&D

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

SC098240

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel